Database for Interstitial Lung Disease

Recruiting

• Conditions: Lung Diseases, Interstitial

• Registration Number: NCT04707781
• Lead Sponsor: Medical University of Graz

Brief Summary

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-01-12
• Study First Submitted QC: 2021-01-12
• Study First Posted: 2021-01-13
• Study Start: 2021-05-01
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-07
• Last Update Posted: 2024-10-09
• Primary Completion: 2026-01-31
• Study Completion: 2026-01-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 412

Inclusion Criteria

• Age: ≥ 18 years
• patients with a known systemic disease bearing a risk for ILD
• signed informed consent (for prospective part)

Exclusion Criteria

• Age < 18 years
• comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis	5 years	The investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis

Secondary Outcome Measures

Name	Time	Method
FVC%pred (Forced vital capacity) at time of ILD diagnosis	5 years	The investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis

Trial Locations

Locations (1)

Medical University of Graz, Department of Internal Medicine, Division of Pulmonology; 🇦🇹 Graz, Austria